Antonio Inforzato graduated in Chemistry (Biological Chemistry Curriculum) at the University of Naples Federico II (2001) and obtained a PhD in Immunology from the University of Rome Tor Vergata (2006). He completed his training in Immunology at the Leiden University Medical Center (Leiden, The Netherlands; 2005) and the Medical Research Council (MRC) Immunochemistry Unit, University of Oxford (Oxford, UK; 2006), and in Biochemistry/Biophysics at the Faculty of Life Sciences, University of Manchester (Manchester, UK, 2006-2009).

He was appointed Assistant Professor of Healthcare Professions and Medical Technologies (MED/46) at the University of Milan (2014-2017), Assistant Professor of Biochemistry (BIO/10) at Humanitas University (2018-2021), and currently holds a position of Associate Professor of Biochemistry (BIO/10) at Humanitas University (since March 2021). Antonio has served at IRCCS Humanitas Research Hospital (HRH) as Senior Scientist in the Laboratory of Immunopharmacology (2009-2022), and Head of Unit in the Laboratory of Cellular and Humoral Innate Immunity (since 2023).

He is the author of 44 publications and 2 book chapters indexed in Pubmed, 17 proceedings, and 1 commentary, with an average impact factor of 7.7 and an h-index of 27 (Scopus) & 28 (Google Scholar), and co-inventor of 2 patents.

Antonio’s scientific interests primarily focus on structure/function of soluble components of the innate immune system in health and disease. Particular attention is paid to the long pentraxin PTX3, as a paradigm of the innate humoral response in opportunistic infections, immuno-degenerative diseases, matrix remodeling and inflammation.